vs
Helmerich & Payne, Inc.（HP）与通用电气医疗（OPCH）财务数据对比。点击上方公司名可切换其他公司
通用电气医疗的季度营收约是Helmerich & Payne, Inc.的1.5倍（$1.4B vs $981.1M），通用电气医疗净利率更高（3.6% vs -9.9%，领先13.5%），Helmerich & Payne, Inc.同比增速更快（45.4% vs 12.2%），通用电气医疗自由现金流更多（$130.2M vs $114.9M），过去两年Helmerich & Payne, Inc.的营收复合增速更高（19.7% vs 13.0%）
Helmerich & Payne（简称H&P）是总部位于美国俄克拉荷马州塔尔萨的跨国石油钻探承包商，为油气勘探开发企业提供钻井及相关配套服务。公司1998年推出的FlexRigs系列钻井平台广泛应用于非常规页岩地层钻探作业，是全球最大的陆上钻探服务商之一。
通用电气医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，旗下设四大业务板块：医学影像（含分子成像、CT、磁共振、女性健康筛查及X线设备）、超声、患者护理解决方案（覆盖远程患者监测、麻醉呼吸护理、心脏病诊断、婴儿护理等）及制药相关业务。
HP vs OPCH — 直观对比
营收规模更大
OPCH
是对方的1.5倍
$981.1M
营收增速更快
HP
高出33.2%
12.2%
净利率更高
OPCH
高出13.5%
-9.9%
自由现金流更多
OPCH
多$15.4M
$114.9M
两年增速更快
HP
近两年复合增速
13.0%
损益表 — Q1 FY2026 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $981.1M | $1.4B |
| 净利润 | $-96.7M | $51.8M |
| 毛利率 | — | 19.0% |
| 营业利润率 | -6.1% | 5.9% |
| 净利率 | -9.9% | 3.6% |
| 营收同比 | 45.4% | 12.2% |
| 净利润同比 | -276.6% | -3.8% |
| 每股收益（稀释后） | $-0.98 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HPOPCH
| Q4 25 | $981.1M | — | ||
| Q3 25 | $953.8M | $1.4B | ||
| Q2 25 | $1.0B | $1.4B | ||
| Q1 25 | $1.0B | $1.3B | ||
| Q4 24 | $674.6M | $1.3B | ||
| Q3 24 | $691.3M | $1.3B | ||
| Q2 24 | $695.1M | $1.2B | ||
| Q1 24 | $685.1M | $1.1B |
净利润HPOPCH
| Q4 25 | $-96.7M | — | ||
| Q3 25 | $-57.4M | $51.8M | ||
| Q2 25 | $-162.8M | $50.5M | ||
| Q1 25 | $1.7M | $46.7M | ||
| Q4 24 | $54.8M | $60.1M | ||
| Q3 24 | $75.5M | $53.9M | ||
| Q2 24 | $88.7M | $53.0M | ||
| Q1 24 | $84.8M | $44.8M |
毛利率HPOPCH
| Q4 25 | — | — | ||
| Q3 25 | — | 19.0% | ||
| Q2 25 | — | 19.0% | ||
| Q1 25 | — | 19.7% | ||
| Q4 24 | — | 21.3% | ||
| Q3 24 | — | 20.1% | ||
| Q2 24 | — | 20.3% | ||
| Q1 24 | — | 20.8% |
营业利润率HPOPCH
| Q4 25 | -6.1% | — | ||
| Q3 25 | -0.1% | 5.9% | ||
| Q2 25 | -12.4% | 5.8% | ||
| Q1 25 | 4.2% | 5.9% | ||
| Q4 24 | 13.3% | 6.9% | ||
| Q3 24 | 15.4% | 6.7% | ||
| Q2 24 | 16.0% | 6.6% | ||
| Q1 24 | 16.1% | 6.0% |
净利率HPOPCH
| Q4 25 | -9.9% | — | ||
| Q3 25 | -6.0% | 3.6% | ||
| Q2 25 | -15.7% | 3.6% | ||
| Q1 25 | 0.2% | 3.5% | ||
| Q4 24 | 8.1% | 4.8% | ||
| Q3 24 | 10.9% | 4.2% | ||
| Q2 24 | 12.8% | 4.3% | ||
| Q1 24 | 12.4% | 3.9% |
每股收益（稀释后）HPOPCH
| Q4 25 | $-0.98 | — | ||
| Q3 25 | $-0.57 | $0.32 | ||
| Q2 25 | $-1.64 | $0.31 | ||
| Q1 25 | $0.01 | $0.28 | ||
| Q4 24 | $0.54 | $0.36 | ||
| Q3 24 | $0.77 | $0.31 | ||
| Q2 24 | $0.88 | $0.30 | ||
| Q1 24 | $0.84 | $0.26 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $269.0M | $309.8M |
| 总债务越低越好 | $2.0B | $1.2B |
| 股东权益账面价值 | $2.7B | $1.4B |
| 总资产 | $6.5B | $3.5B |
| 负债/权益比越低杠杆越低 | 0.75× | 0.86× |
8季度趋势，按日历期对齐
现金及短期投资HPOPCH
| Q4 25 | $269.0M | — | ||
| Q3 25 | $218.3M | $309.8M | ||
| Q2 25 | $187.4M | $198.8M | ||
| Q1 25 | $195.6M | $171.4M | ||
| Q4 24 | $526.5M | $412.6M | ||
| Q3 24 | $510.3M | $483.0M | ||
| Q2 24 | $289.7M | $376.9M | ||
| Q1 24 | $277.0M | $219.5M |
总债务HPOPCH
| Q4 25 | $2.0B | — | ||
| Q3 25 | $2.1B | $1.2B | ||
| Q2 25 | $2.2B | $1.1B | ||
| Q1 25 | $2.2B | $1.1B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | $1.8B | $1.1B | ||
| Q2 24 | — | $1.1B | ||
| Q1 24 | — | $1.1B |
股东权益HPOPCH
| Q4 25 | $2.7B | — | ||
| Q3 25 | $2.8B | $1.4B | ||
| Q2 25 | $2.9B | $1.4B | ||
| Q1 25 | $3.1B | $1.4B | ||
| Q4 24 | $2.9B | $1.4B | ||
| Q3 24 | $2.9B | $1.4B | ||
| Q2 24 | $2.9B | $1.4B | ||
| Q1 24 | $2.8B | $1.4B |
总资产HPOPCH
| Q4 25 | $6.5B | — | ||
| Q3 25 | $6.7B | $3.5B | ||
| Q2 25 | $6.9B | $3.4B | ||
| Q1 25 | $7.2B | $3.3B | ||
| Q4 24 | $5.8B | $3.4B | ||
| Q3 24 | $5.8B | $3.4B | ||
| Q2 24 | $4.5B | $3.3B | ||
| Q1 24 | $4.4B | $3.2B |
负债/权益比HPOPCH
| Q4 25 | 0.75× | — | ||
| Q3 25 | 0.73× | 0.86× | ||
| Q2 25 | 0.76× | 0.82× | ||
| Q1 25 | 0.73× | 0.82× | ||
| Q4 24 | — | 0.79× | ||
| Q3 24 | 0.61× | 0.78× | ||
| Q2 24 | — | 0.79× | ||
| Q1 24 | — | 0.74× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $182.4M | $139.4M |
| 自由现金流经营现金流 - 资本支出 | $114.9M | $130.2M |
| 自由现金流率自由现金流/营收 | 11.7% | 9.1% |
| 资本支出强度资本支出/营收 | 6.9% | 0.6% |
| 现金转化率经营现金流/净利润 | — | 2.69× |
| 过去12个月自由现金流最近4个季度 | $179.6M | $220.7M |
8季度趋势，按日历期对齐
经营现金流HPOPCH
| Q4 25 | $182.4M | — | ||
| Q3 25 | $206.9M | $139.4M | ||
| Q2 25 | $121.6M | $90.3M | ||
| Q1 25 | $56.0M | $-7.2M | ||
| Q4 24 | $158.4M | $36.1M | ||
| Q3 24 | $168.8M | $160.4M | ||
| Q2 24 | $197.4M | $195.7M | ||
| Q1 24 | $143.7M | $-68.8M |
自由现金流HPOPCH
| Q4 25 | $114.9M | — | ||
| Q3 25 | $142.8M | $130.2M | ||
| Q2 25 | $24.6M | $81.2M | ||
| Q1 25 | $-102.7M | $-16.6M | ||
| Q4 24 | $51.9M | $25.8M | ||
| Q3 24 | $62.8M | $150.7M | ||
| Q2 24 | $63.0M | $185.9M | ||
| Q1 24 | $25.4M | $-74.6M |
自由现金流率HPOPCH
| Q4 25 | 11.7% | — | ||
| Q3 25 | 15.0% | 9.1% | ||
| Q2 25 | 2.4% | 5.7% | ||
| Q1 25 | -10.1% | -1.2% | ||
| Q4 24 | 7.7% | 2.0% | ||
| Q3 24 | 9.1% | 11.8% | ||
| Q2 24 | 9.1% | 15.1% | ||
| Q1 24 | 3.7% | -6.5% |
资本支出强度HPOPCH
| Q4 25 | 6.9% | — | ||
| Q3 25 | 6.7% | 0.6% | ||
| Q2 25 | 9.3% | 0.6% | ||
| Q1 25 | 15.7% | 0.7% | ||
| Q4 24 | 15.8% | 0.8% | ||
| Q3 24 | 15.3% | 0.8% | ||
| Q2 24 | 19.3% | 0.8% | ||
| Q1 24 | 17.3% | 0.5% |
现金转化率HPOPCH
| Q4 25 | — | — | ||
| Q3 25 | — | 2.69× | ||
| Q2 25 | — | 1.79× | ||
| Q1 25 | 33.89× | -0.15× | ||
| Q4 24 | 2.89× | 0.60× | ||
| Q3 24 | 2.24× | 2.98× | ||
| Q2 24 | 2.23× | 3.69× | ||
| Q1 24 | 1.69× | -1.54× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HP
| North America Solutions | $563.6M | 57% |
| International Solutions Segment | $229.3M | 23% |
| Offshore Solutions | $188.3M | 19% |
OPCH
| Commercial Customer | $1.3B | 87% |
| Government Customer | $172.8M | 12% |
| Patient Customer | $10.1M | 1% |
| Corporate Joint Venture | $1.9M | 0% |
